Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$31.15 - $33.39 $484,195 - $519,014
-15,544 Reduced 36.14%
27,466 $912,000
Q3 2022

Oct 31, 2022

BUY
$30.9 - $33.55 $660,703 - $717,366
21,382 Added 98.86%
43,010 $1.36 Million
Q2 2022

Jul 29, 2022

SELL
$23.75 - $31.69 $975,175 - $1.3 Million
-41,060 Reduced 65.5%
21,628 $658,000
Q1 2022

Apr 29, 2022

BUY
$19.97 - $26.94 $270,313 - $364,659
13,536 Added 27.54%
62,688 $1.63 Million
Q4 2021

Feb 07, 2022

SELL
$17.46 - $21.61 $74,047 - $91,648
-4,241 Reduced 7.94%
49,152 $1 Million
Q3 2021

Nov 01, 2021

BUY
$17.35 - $22.5 $926,368 - $1.2 Million
53,393 New
53,393 $1.03 Million
Q2 2021

Aug 12, 2021

SELL
$18.01 - $28.32 $174,967 - $275,128
-9,715 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$19.76 - $29.89 $262,966 - $397,776
-13,308 Reduced 57.8%
9,715 $255,000
Q4 2020

Feb 04, 2021

BUY
$15.73 - $21.66 $362,151 - $498,678
23,023 New
23,023 $430,000
Q3 2020

Nov 09, 2020

SELL
$13.54 - $26.41 $375,504 - $732,428
-27,733 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$7.84 - $23.29 $100,516 - $298,601
12,821 Added 85.98%
27,733 $646,000
Q1 2020

Apr 30, 2020

BUY
$5.57 - $11.5 $26,050 - $53,785
4,677 Added 45.7%
14,912 $125,000
Q4 2019

Jan 28, 2020

BUY
$7.9 - $10.14 $80,856 - $103,782
10,235 New
10,235 $100,000
Q2 2019

Jul 29, 2019

SELL
$10.88 - $17.6 $151,678 - $245,361
-13,941 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$15.51 - $17.61 $216,224 - $245,501
13,941 New
13,941 $246,000
Q3 2018

Nov 06, 2018

SELL
$14.85 - $16.35 $174,368 - $191,981
-11,742 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$13.8 - $16.8 $60,775 - $73,987
4,404 Added 60.02%
11,742 $187,000
Q1 2018

May 03, 2018

BUY
$13.8 - $16.2 $101,264 - $118,875
7,338 New
7,338 $104,000
Q4 2017

Jan 24, 2018

SELL
$13.55 - $15.8 $275,756 - $321,545
-20,351 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$13.45 - $14.35 $273,720 - $292,036
20,351
20,351 $291,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.